Tissue expression
Cell line expression

GMPS

gene product
GATD7 
In the de novo synthesis of purine nucleotides, IMP is the branch point metabolite at which point the pathway diverges to the synthesis of either guanine or adenine nucleotides. In the guanine nucleotide pathway, there are 2 enzymes involved in converting IMP to GMP, namely IMP dehydrogenase (IMPD1), which catalyzes the oxidation of IMP to XMP, and GMP synthetase, which catalyzes the amination of XMP to GMP. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Antigen sequence

Conjugate

Epitope

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
256 antibodies from 33 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
Novus Biologicals
7 antibodies
antibodies-online
80 antibodies
Aviva Systems Biology
3 antibodies
Proteintech Group
1 antibody
Abgent
4 antibodies
Abnova Corporation
6 antibodies
Invitrogen Antibodies
6 antibodies
OriGene
4 antibodies
NSJ Bioreagents
1 antibody
Boster Biological Technology
2 antibodies
LifeSpan BioSciences, Inc.
34 antibodies
Cusabio Biotech Co., Ltd
2 antibodies
Acris Antibodies GmbH
7 antibodies
NovoPro Bioscience Inc.
1 antibody
ProSci
4 antibodies
Biorbyt
7 antibodies
Bioworld Technology, Inc
1 antibody
Bethyl Laboratories
2 antibodies
Wuhan Fine Biotech Co., Ltd.
1 antibody
RabMAbs
3 antibodies
GeneTex
2 antibodies
MyBioSource
4 antibodies
Atlas Antibodies
1 antibody
Creative Diagnostics
4 antibodies
Creative Biolabs
7 antibodies
Abiocode, Inc.
1 antibody
Cell Signaling Technology, Inc
1 antibody
RayBiotech, Inc.
1 antibody
St John's Laboratory
1 antibody
United States Biological
35 antibodies
Abbexa
5 antibodies
MilliporeSigma / Merck KGaA
3 antibodies